Digest Network Come funziona
Network
/
Società
Un
Non verificato

United Therapeutics Corporation

Di cosa scriviamo

BiotecnologiaCardiologiaFarmaceuticaMedicina - VarieSalute

80 comunicati stampa

Guarda tutti i comunicati
28/10/2026
Cardiologia
Biotecnologia
Farmaceutica
Sanità
Salute
Igiene alimentare
Medicina - Varie
Industria
United Therapeutics Announces FDA Clearance to Proceed with Clinical Trial for Treprostinil-Iloprost SMI in Pulmonary Arterial Hypertension
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
22/10/2026
Salute
Sanità
Farmaceutica
Biotecnologia
Finanza
United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
21/10/2026
Cardiologia
Biotecnologia
Farmaceutica
Attrezzature medico-sanitarie
Sanità
Salute
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
United Therapeutics Corporation to Report Third Quarter 2026 Financial Results Before Market Open on Wednesday, November 4, 2026
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
20/10/2026
Cardiologia
Biotecnologia
Sanità
Salute
Farmaceutica
Scienza
Medicina - Varie
Industria
United Therapeutics Expands Organ Manufacturing Capabilities with Opening of Third Designated Pathogen-Free Xenograft Production Facility
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
19/10/2026
Scienza
Cardiologia
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Industria
United Therapeutics Announces FDA Clearance to Proceed with SUMMIT Clinical Trial for Treprostinil SMI in PH-COPD
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
08/09/2026
Finanza
Biotecnologia
Farmaceutica
Salute
Cardiologia
United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
02/09/2026
Industria
Cardiologia
Biotecnologia
Farmaceutica
Sanità
Salute
Igiene alimentare
Medicina - Varie
United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
01/09/2026
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Cardiologia
United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
28/08/2026
Eventi
Biotecnologia
Sanità
Salute
Farmaceutica
Cardiologia
United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0
24/08/2026
Industria
Scienza
Cardiologia
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension
Fonte
United Therapeutics Corporation
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0